DE3588225T2 - Anti-Lymphotoxin-Antikörper, Herstellung und Verwendung - Google Patents

Anti-Lymphotoxin-Antikörper, Herstellung und Verwendung

Info

Publication number
DE3588225T2
DE3588225T2 DE3588225T DE3588225T DE3588225T2 DE 3588225 T2 DE3588225 T2 DE 3588225T2 DE 3588225 T DE3588225 T DE 3588225T DE 3588225 T DE3588225 T DE 3588225T DE 3588225 T2 DE3588225 T2 DE 3588225T2
Authority
DE
Germany
Prior art keywords
lymphotoxin
antibody
amino acid
activity
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3588225T
Other languages
German (de)
English (en)
Other versions
DE3588225D1 (de
Inventor
Bharat Bhushan Aggarwal
Timothy Scott Bringman
Patrick William Gray
Glenn Evan Nedwin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/616,502 external-priority patent/US4959457A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE3588225D1 publication Critical patent/DE3588225D1/de
Publication of DE3588225T2 publication Critical patent/DE3588225T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C07K16/242—Lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C07K14/5255—Lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE3588225T 1984-05-31 1985-05-30 Anti-Lymphotoxin-Antikörper, Herstellung und Verwendung Expired - Lifetime DE3588225T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61650384A 1984-05-31 1984-05-31
US06/616,502 US4959457A (en) 1984-05-31 1984-05-31 Anti-lymphotoxin
US73231285A 1985-05-09 1985-05-09

Publications (2)

Publication Number Publication Date
DE3588225D1 DE3588225D1 (de) 2000-09-14
DE3588225T2 true DE3588225T2 (de) 2001-04-05

Family

ID=27417179

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3588225T Expired - Lifetime DE3588225T2 (de) 1984-05-31 1985-05-30 Anti-Lymphotoxin-Antikörper, Herstellung und Verwendung
DE3587597T Expired - Lifetime DE3587597T2 (de) 1984-05-31 1985-05-30 Lymphotoxin, dafür kodierende Nukleinsäure, die Nukleinsäure enthaltenden Vektoren und damit transformierte Zellen, Verfahren zum Erhalten von Lymphotoxin und Lymphotoxin neutralisierender Antikörper.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3587597T Expired - Lifetime DE3587597T2 (de) 1984-05-31 1985-05-30 Lymphotoxin, dafür kodierende Nukleinsäure, die Nukleinsäure enthaltenden Vektoren und damit transformierte Zellen, Verfahren zum Erhalten von Lymphotoxin und Lymphotoxin neutralisierender Antikörper.

Country Status (23)

Country Link
EP (2) EP0509553B1 (https=)
JP (3) JP2521703B2 (https=)
AR (1) AR245219A1 (https=)
AT (2) ATE195323T1 (https=)
AU (1) AU599303B2 (https=)
BG (1) BG60256B2 (https=)
CA (1) CA1340641C (https=)
CZ (1) CZ283148B6 (https=)
DE (2) DE3588225T2 (https=)
DK (1) DK171531B1 (https=)
ES (1) ES8802182A1 (https=)
FI (1) FI93025C (https=)
GR (1) GR851317B (https=)
HU (1) HU204085B (https=)
IE (1) IE63487B1 (https=)
IL (1) IL75318A (https=)
NO (1) NO179075C (https=)
NZ (1) NZ212207A (https=)
PL (1) PL155410B1 (https=)
PT (1) PT80573B (https=)
RO (1) RO100383A2 (https=)
SK (1) SK393085A3 (https=)
YU (1) YU47735B (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041313B1 (en) 1980-04-03 1990-09-12 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon
NZ212207A (en) 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
EP0368367A1 (en) * 1984-12-21 1990-05-16 Biogen, Inc. Purification, production and use of tumor necrosis factors
JPS62195285A (ja) * 1986-02-19 1987-08-28 Kanegafuchi Chem Ind Co Ltd リンホトキシン発現ベクタ−及びそれを用いるリンホトキシンの製造方法
JPS62111928A (ja) * 1985-10-15 1987-05-22 Kanegafuchi Chem Ind Co Ltd 新規リンホトキシン
AU603768B2 (en) * 1985-07-04 1990-11-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin
JP2548204B2 (ja) * 1987-06-27 1996-10-30 電気化学工業株式会社 新生理活性ポリペプチド
DE3686148T2 (de) * 1985-12-24 1993-01-14 Denki Kagaku Kogyo Kk Lymphotoxin-gen, verfahren zu dessen herstellung und lymphotoxin.
US5403725A (en) * 1985-12-24 1995-04-04 Denki Kagaku Kogyo Kabushiki Kaisha Method for production of lymphotoxin (TNFB) in cell line A-C5-8
EP0230574A3 (en) * 1986-01-31 1989-03-22 Yale University Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
JPS62181298A (ja) * 1986-02-05 1987-08-08 Kyowa Hakko Kogyo Co Ltd ヒトリンホトキシンポリペプチド誘導体
DE3620656A1 (de) * 1986-06-20 1987-12-23 Basf Ag Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung
JPS63105680A (ja) * 1986-10-22 1988-05-10 Kanegafuchi Chem Ind Co Ltd ヒト・リンホトキシン発現ベクタ−、該発現ベクタ−による形質転換細胞および該細胞を用いるリンホトキシンの製造方法
EP0272894A3 (en) * 1986-12-24 1989-06-14 Takeda Chemical Industries, Ltd. Recombinant human lymphotoxin
US5175268A (en) * 1986-12-24 1992-12-29 Takeda Chemical Industries, Ltd. DNA encoding recombinant human lymphotoxin
FI884798A7 (fi) * 1987-10-28 1989-04-29 Eisai Co Ltd Rekombinantlymfotoxin.
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
GB2217326B (en) * 1988-04-08 1991-11-20 British Bio Technology Synthetic gene encoding human tumour necrosis factor beta.
EP0338497A3 (en) * 1988-04-22 1990-05-16 Takeda Chemical Industries, Ltd. Bispecific hybrid monoclonal antibody
JPH023698A (ja) * 1988-06-20 1990-01-09 Denki Kagaku Kogyo Kk ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬
CA2001756A1 (en) * 1988-10-31 1991-04-30 Seiichi Uesugi New human lymphotoxin n-end deletion mutant
JPH03106821A (ja) * 1989-09-20 1991-05-07 Denki Kagaku Kogyo Kk 抗腫瘍剤
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin
JP4231106B2 (ja) * 1995-01-23 2009-02-25 ゼノテック インコーポレイティッド 骨溶解および転移を改善する方法
US5925351A (en) 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US6998116B1 (en) 1996-01-09 2006-02-14 Genentech, Inc. Apo-2 ligand
JP2002508962A (ja) 1998-01-15 2002-03-26 ジェネンテク・インコーポレイテッド Ａｐｏ−２リガンド
JP2011516026A (ja) * 2002-11-26 2011-05-26 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための組成物と方法
NZ544924A (en) 2003-06-27 2009-03-31 Biogen Idec Inc Modified binding molecules comprising connecting peptides
EP1699486A4 (en) * 2003-12-08 2007-07-18 Centocor Inc ANTI-LYMPHOTOXIN HUMAN ALPHA ANTIBODIES, COMPOSITIONS, METHODS AND USES
KR20060132006A (ko) 2004-03-23 2006-12-20 비오겐 아이덱 엠에이 아이엔씨. 수용체 커플링제 및 이의 치료적 용도
WO2006074399A2 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
UA94484C2 (uk) * 2006-10-12 2011-05-10 Дженентек, Інк. Антитіла до лімфотоксину-альфа
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
CN101600450A (zh) 2006-10-20 2009-12-09 比奥根艾迪克Ma公司 利用可溶性淋巴毒素β受体的脱髓鞘病的治疗
JP6702883B2 (ja) * 2014-04-25 2020-06-03 ノーレックス インコーポレイテッド 向神経活性ペプチドの安定な組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU88258I2 (https=) * 1978-12-22 1994-02-03
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins
DE3331108A1 (de) * 1983-08-30 1985-05-02 Boehringer Ingelheim International GmbH, 6507 Ingelheim Verfahren zur herstellung von lymphotoxin und von lymphotoxin-mrna
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
NZ212207A (en) 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin

Also Published As

Publication number Publication date
EP0164965A3 (en) 1988-04-06
JPH07291995A (ja) 1995-11-07
PT80573A (en) 1985-06-01
JP2521703B2 (ja) 1996-08-07
CZ283148B6 (cs) 1998-01-14
JP2804237B2 (ja) 1998-09-24
ATE95243T1 (de) 1993-10-15
DE3587597T2 (de) 1994-06-01
IE63487B1 (en) 1995-05-03
AU599303B2 (en) 1990-07-19
FI93025B (fi) 1994-10-31
EP0509553B1 (en) 2000-08-09
IE851321L (en) 1985-11-30
PL155410B1 (en) 1991-11-29
NZ212207A (en) 1991-07-26
ATE195323T1 (de) 2000-08-15
CA1340641C (en) 1999-07-13
EP0164965B1 (en) 1993-09-29
IL75318A (en) 1994-08-26
DK171531B1 (da) 1996-12-23
PT80573B (pt) 1987-08-19
YU47735B (sh) 1996-01-08
CZ393085A3 (en) 1997-07-16
DE3587597D1 (de) 1993-11-04
RO100383B1 (ro) 1991-03-01
AU4320385A (en) 1985-12-05
BG60256B1 (bg) 1994-03-24
JPH07250692A (ja) 1995-10-03
RO100383A2 (ro) 1991-10-17
BG60256B2 (bg) 1994-03-24
IL75318A0 (en) 1985-09-29
PL253739A1 (en) 1986-03-11
SK278333B6 (en) 1996-11-06
SK393085A3 (en) 1996-11-06
DK241385A (da) 1985-12-01
ES543695A0 (es) 1988-04-16
IE930589L (en) 1985-11-30
GR851317B (https=) 1985-11-25
FI852143A0 (fi) 1985-05-29
NO179075B (no) 1996-04-22
AR245219A1 (es) 1993-12-30
FI852143L (fi) 1985-12-01
HUT37814A (en) 1986-02-28
EP0509553A1 (en) 1992-10-21
JPS6156197A (ja) 1986-03-20
YU91985A (en) 1988-12-31
NO852173L (no) 1985-12-02
FI93025C (fi) 1995-02-10
HU204085B (en) 1991-11-28
ES8802182A1 (es) 1988-04-16
DK241385D0 (da) 1985-05-30
NO179075C (no) 1996-07-31
DE3588225D1 (de) 2000-09-14
EP0164965A2 (en) 1985-12-18

Similar Documents

Publication Publication Date Title
DE3588225T2 (de) Anti-Lymphotoxin-Antikörper, Herstellung und Verwendung
DE3650267T2 (de) Die alpha- oder beta-Ketten von Inhibin codierende Nukleinsäure und Verfahren zur Synthese von Polypeptiden unter Verwendung einer solchen Nukleinsäure.
DE3855536T2 (de) Rezeptoren für wachstumshormone
DE68929387T2 (de) Interleukin-1-Inhibitoren
DE69432629T3 (de) Antikörper gegen beta-amyloid oder derivative davon und seine verwendung
DE69029545T2 (de) Menschliches GP130-Protein codierende DNS
DE68916537T3 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
DE68927088T2 (de) Menschlicher Gefässpermeabilitätsfaktor
DE69034244T2 (de) Zytotoxischer Lymphozyten-Reifefaktor 35kD Untereinheit und monoklonale Antikörper spezifisch dafür
DE69028671T3 (de) Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
Podlaski et al. Molecular characterization of interleukin 12
DE3689734T2 (de) Gereinigter immunoglobulinbezüglicher Faktor, monoklonale Antikörper, Hybridoma-Zellinien, Verfahren und Verwendungen.
US4490289A (en) Homogeneous human interleukin 2
DE69031997T2 (de) TNF(Tumor Necrosis Factor)-Inhibitor und Verfahren zur Herstellung
JP3192651B2 (ja) インターロイキン―１インヒビター
DE4423131A1 (de) Neue hIL-4-Mutantenproteine als Antagonisten oder partielle Agonisten des humanen Interleukin 4
DE69726571T2 (de) Rekombinantes humanes Erythropoietin mit vorteilhaftem Glykosylierungsmuster
DE69012377T2 (de) Polypeptid und dessen Herstellung.
DE3750379T3 (de) Varianten des abbaubeschleunigenden Faktors (DAF), hergestellt durch rekombinante DNS-Technologie.
US5484887A (en) Homogeneous interleukin 1
US6177543B1 (en) Recombinant lymphotoxin
DE3750664T2 (de) Throminbindende Substanz und Verfahren zu ihrer Herstellung.
DE3885752T2 (de) Methode und verbindungen zur herstellung von acsf und acsf-antagonisten.
DE68928902T2 (de) Monoklonaler Antikörper gegen menschliches Lymphotoxin und seine Verwendung
DE3587721T2 (de) Hormone und Verfahren zur Herstellung, Verwendung und Prüfung derselben.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition